290 related articles for article (PubMed ID: 11069811)
1. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
[TBL] [Abstract][Full Text] [Related]
2. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease.
Lapperre TS; Snoeck-Stroband JB; Gosman MM; Stolk J; Sont JK; Jansen DF; Kerstjens HA; Postma DS; Sterk PJ;
Am J Respir Crit Care Med; 2004 Sep; 170(5):499-504. PubMed ID: 15172889
[TBL] [Abstract][Full Text] [Related]
4. Exhaled nitric oxide in chronic obstructive pulmonary disease.
Maziak W; Loukides S; Culpitt S; Sullivan P; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):998-1002. PubMed ID: 9517624
[TBL] [Abstract][Full Text] [Related]
5. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
[TBL] [Abstract][Full Text] [Related]
7. The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma.
Tsuburai T; Tsurikisawa N; Taniguchi M; Morita S; Ono E; Oshikata C; Ohtomo M; Maeda Y; Ikehara K; Akiyama K
Allergol Int; 2007 Mar; 56(1):37-43. PubMed ID: 17259808
[TBL] [Abstract][Full Text] [Related]
8. Evidence of lower oxidative stress in the air spaces of patients with reversible COPD.
Serviddio G; Carpagnano GE; Rollo T; Tamborra R; Foschino Barbaro MP; Vendemiale G; Altomare E
Int J Immunopathol Pharmacol; 2006; 19(3):617-28. PubMed ID: 17026847
[TBL] [Abstract][Full Text] [Related]
9. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
Hadcroft J; Calverley PM
Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
[TBL] [Abstract][Full Text] [Related]
10. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
11. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment.
Leigh R; Pizzichini MM; Morris MM; Maltais F; Hargreave FE; Pizzichini E
Eur Respir J; 2006 May; 27(5):964-71. PubMed ID: 16446316
[TBL] [Abstract][Full Text] [Related]
12. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS
Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200
[TBL] [Abstract][Full Text] [Related]
13. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
Belman MJ; Botnick WC; Shin JW
Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
[TBL] [Abstract][Full Text] [Related]
14. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma.
Kostikas K; Gaga M; Papatheodorou G; Karamanis T; Orphanidou D; Loukides S
Chest; 2005 May; 127(5):1553-9. PubMed ID: 15888827
[TBL] [Abstract][Full Text] [Related]
16. [Response to inhaled bronchodilators in chronic airway obstruction].
Holten K
Tidsskr Nor Laegeforen; 1993 Feb; 113(4):444-7. PubMed ID: 8465284
[TBL] [Abstract][Full Text] [Related]
17. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
18. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease.
Kanazawa H; Shoji S; Yoshikawa T; Hirata K; Yoshikawa J
Clin Exp Allergy; 1998 Oct; 28(10):1244-50. PubMed ID: 9824391
[TBL] [Abstract][Full Text] [Related]
19. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease.
Taube C; Holz O; Mücke M; Jörres RA; Magnussen H
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1810-5. PubMed ID: 11734428
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of budesonide on inflammatory status in COPD.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2008 Apr; 5(2):97-104. PubMed ID: 18415808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
